GlassScriptPhysician profile
Madhu Mehta
NPI 1417964966
$3,217.65
in general payments reported to CMS, 2019-2025
25 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $787 · 2021: $598 · 2022: $143 · 2023: $63.93 · 2024: $19.98 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $713.23 | 2019-2025 | Tavneos |
| Abbvie INC. | $659.68 | 2019-2023 | |
| Ucb, INC. | $360.21 | 2019-2025 | Bimzelx |
| Pfizer INC. | $276.23 | 2019-2025 | |
| Glaxosmithkline, LLC. | $257.02 | 2019-2021 | |
| Lilly USA, LLC | $140.81 | 2019-2025 | Zepbound, Taltz |
| Janssen Biotech, INC. | $136.05 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $127.36 | 2019-2023 | |
| Boston Scientific Corporation | $107.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $71.92 | 2019-2020 | |
| Celgene Corporation | $56.75 | 2019 | |
| Mallinckrodt Enterprises LLC | $43.62 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $38.33 | 2019 | |
| Mallinckrodt Hospital Products INC. | $34.58 | 2020 | |
| Amarin Pharma, INC. | $34.31 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $25.72 | 2020 | |
| Alexion Pharmaceuticals, INC. | $25.08 | 2019 | |
| Hikma Pharmaceuticals USA | $20.60 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.33 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $14.81 | 2021 | |
| Antares Pharma, INC. | $12.72 | 2019 | |
| Radius Health, INC. | $12.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhu Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.